1. Foltinova, V., Svihalkova, Sindlerova, L., Horvath, V., Sova, P., Hofmanova, J. et al. (2008). Mechanisms of effects of platinum(II) and (IV) complexes. Comparison of cisplatin and oxaliplatin with satraplatin and LA-12, new Pt(IV)-based drugs. SCRIPTA MEDICA (BRNO), 81(2), 105–116.
2. Van-Rijt, S. H., & Sadler, P. J. (2009). Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Drug Discovery Today, 14(23–24), 1089–1097.
3. Eastman, A. (1990). Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2(8–9), 275–280.
4. WoŸniak, K., & Błasiak, J. (2002). Recognition and repair of DNA-cisplatin adducts. Acta Biochimica Polonica, 49, 583–596.
5. Bosl, G. J., & Motzer, R. J. (1997). Testicular germ-cell cancer. The New England Journal of Medicine, 337(4), 242–254.